Glucuronidation of the red clover isoflavone irilone by liver microsomes from different species and human UDP-glucuronosyltransferases

Drug Metabolism and Disposition

Volumn 39, Issue 4, 2011, Pages 610-616

  Maul, Ronald ^b,c   Siegl, Diana ^b   Kulling, Sabine E ^a  

^a FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c BAM FEDERAL INSTITUTE FOR MATERIALS RESEARCH AND TESTING   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1A10; CYTOCHROME P450 1A7; CYTOCHROME P450 1A8; CYTOCHROME P450 1A9; CYTOCHROME P450 2B15; GLUCURONOSYLTRANSFERASE; IRILONE; IRILONE O 4' MONOGLUCURONIDE; IRILONE O 5 MONOGLUCURONIDE; ISOFLAVONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG GLUCURONIDATION; ENZYME KINETICS; ENZYME SPECIFICITY; HUMAN; LIVER MICROSOME; NONHUMAN; PRIORITY JOURNAL; RAT; RED CLOVER; SPECIES DIFFERENCE; SWINE;

ANIMALS; BONE DENSITY CONSERVATION AGENTS; FEMALE; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; ISOFLAVONES; LIVER; MALE; MENOPAUSE; MICROSOMES, LIVER; MODELS, THEORETICAL; RATS; RATS, SPRAGUE-DAWLEY; SWINE; TRIFOLIUM;

RATTUS; SUS; TRIFOLIUM PRATENSE;

EID: 79952850454     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.110.033076     Document Type: Article

References (31)

1. Adlercreutz H, van der Wildt J, Kinzel J, Attalla H, Wähä lä K, Mäkelä T, Hase T, and Fotsis T (1995) Lignan and isoflavonoid conjugates in human urine. J Steroid Biochem Mol Biol 52:97-103.
2. Braune A, Maul R, Schebb NH, Kulling SE, and Blaut M (2010) The red clover isoflavone irilone is largely resistant to degradation by the human gut microbiota. Mol Nutr Food Res 54:929-938.
3. Doerge DR, Chang HC, Churchwell MI, and Holder CL (2000) Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab Dispos 28:298-307. (Pubitemid 30137054)
4. Finel M and Kurkela M (2008) The UDP-glucuronosyltransferases as oligomeric enzymes. Curr Drug Metab 9:70-76. (Pubitemid 351201672)
5. Fisher MB, Campanale K, Ackermann BL, VandenBranden M, and Wrighton SA (2000) In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metab Dispos 28:560-566. (Pubitemid 30238515)
6. Heinonen SM, Wähälä K, and Adlercreutz H (2004) Identification of urinary metabolites of the red clover isoflavones formononetin and biochanin A in human subjects. J Agric Food Chem 52:6802-6809.
7. Helferich WG, Andrade JE, and Hoagland MS (2008) Phytoestrogens and breast cancer: a complex story. Inflammopharmacology 16:219-226.
8. Hendrich S (2002) Bioavailability of isoflavones. J Chromatogr B Analyt Technol Biomed Life Sci 777:203-210.
9. Houston JB and Kenworthy KE (2000) In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model. Drug Metab Dispos 28:246-254. (Pubitemid 30137047)
10. Howes J, Waring M, Huang L, and Howes LG (2002) Long-term pharmacokinetics of an extract of isoflavones from red clover (Trifolium pratense). J Altern Complement Med 8:135-142. (Pubitemid 34438486)
11. Jacobs A, Wegewitz U, Sommerfeld C, Grossklaus R, and Lampen A (2009) Efficacy of isoflavones in relieving vasomotor menopausal symptoms - A systematic review. Mol Nutr Food Res 53:1084-1097.
12. Joseph TB, Wang SW, Liu X, Kulkarni KH, Wang J, Xu H, and Hu M (2007) Disposition of flavonoids via enteric recycling: enzyme stability affects characterization of prunetin glucuronidation across species, organs, and UGT isoforms. Mol Pharm 4:883-894.
13. Kelly GE, Nelson C, Waring MA, Joannou GE, and Reeder AY (1993) Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta 223:9-22. (Pubitemid 24050906)
14. King RA and Bursill DB (1998) Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans. Am J Clin Nutr 67:867-872. (Pubitemid 28196660)
15. Lake BG (1987) Preparation and characterization of microsomal fractions for studies on xenobiotic metabolism, in Biochemical Toxicology: A Practical Approach (Snell K and Mullock B eds) pp 183-215, IRL Press, Oxford.
16. Lampe JW (2009) Is equol the key to the efficacy of soy foods? Am J Clin Nutr 89:1664S-1667S.
17. Larkin T, Price WE, and Astheimer L (2008) The key importance of soy isoflavone bioavailability to understanding health benefits. Crit Rev Food Sci Nutr 48:538-552. (Pubitemid 351883144)
18. Lépine J, Bernard O, Plante M, Têtu B, Pelletier G, Labrie F, Bélanger A, and Guillemette C (2004) Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphosphoglucuronosyltransferases expressed in endometrium. J Clin Endocrinol Metab 89:5222-5232. (Pubitemid 39391472)
19. Liu J, Ho SC, Su YX, Chen WQ, Zhang CX, and Chen YM (2009) Effect of long-term intervention of soy isoflavones on bone mineral density in women: a meta-analysis of randomized controlled trials. Bone 44:948-953.
20. Matern H, Heinemann H, and Matern S (1994) Radioassay of UDP-glucuronosyltransferase activities toward endogenous substrates using labeled UDP-glucuronic acid and an organic solvent extraction procedure. Anal Biochem 219:182-188.
21. Maul R and Kulling SE (2010) Absorption of red clover isoflavones in human subjects: results from a pilot study. Br J Nutr 103:1569-1572.
22. Miners JO, Mackenzie PI, and Knights KM (2010) The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential. Drug Metab Rev 42:189-201.
23. Pritchett LE, Atherton KM, Mutch E, and Ford D (2008) Glucuronidation of the soyabean isoflavones genistein and daidzein by human liver is related to levels of UGT1A1 and UGT1A9 activity and alters isoflavone response in the MCF-7 human breast cancer cell line. J Nutr Biochem 19:739-745.
24. Richelle M, Pridmore-Merten S, Bodenstab S, Enslen M, and Offord EA (2002) Hydrolysis of isoflavone glycosides to aglycones by β-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women. J Nutr 132:2587-2592. (Pubitemid 35013238)
25. Rüfer CE, Maul R, Donauer E, Fabian EJ, and Kulling SE (2007) In vitro and in vivo metabolism of the soy isoflavone glycitein. Mol Nutr Food Res 51:813-823. (Pubitemid 47173691)
26. Sfakianos J, Coward L, Kirk M, and Barnes S (1997) Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J Nutr 127:1260-1268. (Pubitemid 27283989)
27. Soars MG, Ring BJ, and Wrighton SA (2003) The effect of incubation conditions on the enzyme kinetics of udp-glucuronosyltransferases. Drug Metab Dispos 31:762-767. (Pubitemid 36617665)
28. Takimoto, Glover K, Huang X, and Hayes SA (2003) Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer. Cancer Epidemiol Biomarkers Prev 12:1213-1221. (Pubitemid 37499447)
29. Tukey RH and Strassburg CP (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581-616. (Pubitemid 30340694)
30. Ueng YF, Hsieh CH, and Don MJ (2005) Inhibition of human cytochrome P450 enzymes by the natural hepatotoxin safrole. Food Chem Toxicol 43:707-712.
31. Velpandian T, Jasuja R, Bhardwaj RK, Jaiswal J, and Gupta SK (2001) Piperine in food: interference in the pharmacokinetics of phenytoin. Eur J Drug Metab Pharmacokinet 26:241-247. (Pubitemid 34076170)